You are here

VX-509

Vertex reports positive results from Phase 2 study of VX-509

Yahoo/The Fly on the Wall

Sat, 10/19/13 - 03:51 pm

Vertex Pharmaceuticals

rheumatoid arthritis

Phase 2 Data for Selective Oral JAK3 Inhibitor VX-509 Show Significant Improvements in Signs and Symptoms of Rheumatoid Arthritis

Yahoo/BusinessWire

Sun, 11/6/11 - 11:59 am

Vertex Pharmaceuticals

JAK3 inhibitors

rheumatoid arthritis

Vertex Arthritis Pill Shines in Mid-Stage Study

TheStreet.com

Tue, 09/6/11 - 12:10 pm

rheumatoid arthritis